Dominican company based in Santo Domingo · We only ship within the Dominican Republic · No international shippingDominican Republic only · No international shipping
ES Home Catalog Education COAs Calculator Founder
DSIP
Renova Verification
  • ✓≥99% purity by HPLC + mass spectrometry
  • ✓Independent Janoshik 3rd-party analysis
  • ✓−20°C lyophilized · 2–8°C reconstituted
🧪 View COA →
Home › Products › Cognitivo & Sleep › DSIP
← Back to catalog Cognitivo & SleepAvailable

DSIP (15 mg)

SleepDelta wavesCircadian
$170 USD15 mg/vial
🧪 Bacteriostatic water — needed to reconstitute the lyophilized vial
💰 Buy by volume
3+ of one
Save 15%
5+ of one
Save 25%
★ Wholesale
10+ of one
Save 40%
🔀 Mix & Match · across different products: 3+ items 10% · 5+ 15% · 7+ 20%
The best discount per product is applied automatically at checkout (they don't stack). Excludes bacteriostatic water; Retatrutide and Tirzepatide only get same-product volume. Can't be combined with promo codes.
🧪 COA❄️ Cold chain🛡️ Replacement guarantee🔒 Secure payment📦 Nationwide shipping🇺🇸 cGMP · ISO 9001 guidelines · COA

Delta sleep-inducing peptide — natural regulator of deep sleep and circadian rhythms. Discovered in hibernating rabbit brain.

  • Mechanism: Delta sleep-inducing peptide; mechanism poorly defined.
  • Evidence: Old and limited human studies (sleep, pain), with mixed results.
  • In context: Safety and efficacy profile poorly characterized.
Research range · SC
100–300 mcg per application · at night
🔴 Research convention · clinical data was IV

Ranges cited in research literature. Not a usage recommendation. For research use only.

📋 Technical datasheet · Compound specifications
CompoundDSIP
Origin🇺🇸 From US-based suppliers that follow strict cGMP & ISO 9001 guidelines
FormLyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formulaC35H48N10O15
Molecular weight848.81 g/mol
SequenceTrp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (9-mer)
Purity≥99% by HPLC + mass spectrometry (Janoshik Analytical)
StorageLyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C · stability varies by peptide (see the reconstitution guide and the product COA)
Recommended solventBacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain2–8°C in transit · controlled thermal packaging
UseResearch Use Only (RUO). Not intended for human or veterinary use.

Typical values for this compound category. For product-specific data, see the corresponding COA at /en/coa/.

This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.

DSIP: research profile

DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide — Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu — isolated in 1977 by Guido Schoenenberger and Marcel Monnier in Basel from the cerebral venous blood of rabbits under sleep-inducing thalamic stimulation. It is one of the oldest sleep peptides in the literature and, almost fifty years later, it still has no identified receptor and no clear precursor gene in the human genome, which makes it a peculiar molecule.

In the original rabbit and rat studies it increased slow-wave (delta) sleep, and later work attributed to it effects on LH, GH and somatostatin secretion, on the stress response and on body temperature, with results that varied by model. It has been proposed to act by modulating NMDA receptors and calcium channels, and a phosphorylated fragment is said to be more stable, but none of these hypotheses has been consolidated. Its plasma half-life is minutes.

Human evidence comes from small trials in the 1980s and 1990s in insomnia, chronic pain and withdrawal syndromes, by the intravenous route and with mixed results: some described improved sleep and others no effect. It has not been developed as a drug and is not approved in any country. The research market's subcutaneous convention has no clinical data. Renova distributes it for research only.

DSIP technical data

ClassEndogenous nonapeptide associated with slow-wave sleep
SequenceTrp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (9 aa)
CAS62568-57-4
DiscoverySchoenenberger and Monnier, Basel, 1977 (rabbit cerebral blood)
ReceptorNot identified; hypotheses: NMDA modulation, calcium channels
Half-lifeMinutes in plasma
Human dataSmall IV trials (1980s–90s) in insomnia, pain and withdrawal; mixed results
Regulatory statusNot approved in any country

Questions about DSIP

How was DSIP discovered?

In 1977, in Basel: Schoenenberger and Monnier stimulated the thalamus of rabbits to induce sleep, collected their cerebral venous blood and infused it into other rabbits, which also fell asleep. Isolating the responsible factor yielded this nonapeptide. Hence its name, delta sleep-inducing peptide.

Is the DSIP receptor known?

No. Unlike almost every peptide in the catalog, DSIP has no identified receptor and no clear precursor gene in the human genome. Interactions with NMDA receptors and calcium channels have been proposed, but they remain unconfirmed hypotheses.

What did the human studies show?

They were small, intravenous and decades old: in insomnia some described more slow-wave sleep and others no change; in chronic pain and opioid and alcohol withdrawal there were positive signals without later confirmation. Taken together, the evidence is insufficient for conclusions.

Why is DSIP also associated with hormones and stress?

Because in animal studies it altered LH, GH and somatostatin secretion and blunted the corticosterone response to stress, besides affecting body temperature. That diversity of effects without a known receptor is part of what keeps scientific interest in the molecule alive.

Related reading: DSIP: Delta Sleep-Inducing Peptide

Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.

Questions? Write us

Your Order

Your cart is empty